ArticlePDF Available

CA19-9 LOWERING EFFECT OF AN AYURVEDIC MINERAL COMPLEX PREPARED USING COPPER, MERCURY AND SULPHUR

Authors:
  • VCP Cancer Research Foundation
  • Padaav Speciality Ayurvedic Treatment Center
  • Vcp cancer research center
  • VCP Cancer Research Foundation, Dehradun

Abstract and Figures

Rasa Shastra is a branch of Ayurveda that deals with the therapeutics of metals and minerals. It emphasizes on the essentiality of balance of metals and minerals in body tissues for the regulation of body metabolism. The role of metal based Ayurvedic formulations has been explored in various disorders. Here, we discuss about an Ayurvedic Mineral Complex (AMC) that is being used to bring sustainable and complete relief in patients of Pancreatitis. A recent observation deciphers the involvement of AMC in bringing down elevated CA19-9 levels in pancreatitis patients. CA19-9 is a tumor marker largely used to monitor the disease course of pancreatitis and pancreatic cancer. Increasing levels of CA19-9 signify progression of disease while decreasing levels are indicative of regression. The findings of this study could open a new thrust area for research to develop this formulation as a preventive therapy for pancreatic cancer in patients suffering from Pancreatitis.
Content may be subject to copyright.
Ay. Darpan J., Volume 11, Issue 1, Page 19-22 (2020)
[19]
Research article
CA19-9 LOWERING EFFECT OF AN AYURVEDIC MINERAL
COMPLEX PREPARED USING COPPER, MERCURY AND SULPHUR
Vaidya Balendu Prakash1*, Vaidya Shikha Prakash2, Shakshi Sharma2, Sneha Tiwari1,
Vaidya Pooja Jaryal2, Jyoti Tewari1 and Meenakshi Joshi1
1VCPC Research Foundation, Danpur, Rudrapur, Uttarakhand, India.
2Padaav-Speciality Ayurvedic Treatment Centre, Uttarakhand, India.
*Corresponding Author. Email: balenduprakash@gmail.com; Phone: +91-9837028544
Abstract
Rasa Shastra is a branch of Ayurveda that deals with the therapeutics of metals and minerals. It emphasizes on the
essentiality of balance of metals and minerals in body tissues for the regulation of body metabolism. The role of
metal based Ayurvedic formulations has been explored in various disorders. Here, we discuss about an Ayurvedic
Mineral Complex (AMC) that is being used to bring sustainable and complete relief in patients of Pancreatitis. A
recent observation deciphers the involvement of AMC in bringing down elevated CA19-9 levels in pancreatitis
patients. CA19-9 is a tumor marker largely used to monitor the disease course of pancreatitis and pancreatic cancer.
Increasing levels of CA19-9 signify progression of disease while decreasing levels are indicative of regression. The
findings of this study could open a new thrust area for research to develop this formulation as a preventive therapy
for pancreatic cancer in patients suffering from Pancreatitis.
Keywords: Ayurvedic Mineral Complex, Rasa Shastra, Pancreatitis, Ayurveda
INTRODUCTION
The word dhatu’ is derived from dharanat dhatavah’,
meaning that which bears is called dhatu1. Ayurvedic
literature has used the word dhatu for rasa, rakta,
mansa, medha, asthi, majja, shukra, and the same word
is also used for seven elements of the periodic table,
Gold, Silver, Copper, Iron, Zinc, Tin and Lead1. Rasa
Shastra has described a close linkage between both the
dhatus for a healthy state of the human body. The
imbalance of elemental dhatu in the tissue dhatu might
lead to disturbed metabolism and cause diseases2.
Copper, the 29th element of the periodic table, is
found to be present in body tissues, including liver,
muscles and bones and has special effect of an anti-
inflammatory3,4. However, Copper is also described to
be toxic in raw form as well as in certain salt forms5,6.
Therefore, great emphasis has been laid on its
processing; shodhan and maran.
In early seventies, Meerut based Late Vaidya
Chandra Prakash ji made a unique attempt for the
processing of Copper. He first made an amalgam of
shodhit tamra (Copper) with hinguloth + tamroth +
vishoth parad (Mercury) and subjected that to shatguna
gandhak jarana using nalika baluka yantra. This
Ayurvedic Mineral Complex (AMC) prepared in nearly
three years reportedly miraculously brought complete
and sustainable recovery to a terminally ill patient
suffering from pancreatic cancer7.
Over the years, AMC has continued to exhibit
therapeutic effect in certain forms of cancers along with
chronic and progressive inflammatory disorders, more
specifically in bringing complete and sustainable relief
to the patients of Recurrent Acute/ Chronic
Pancreatitis8,9. This formulation was studied for process
characterization and standardization at Indian Institute
of Science, Bengaluru. Analysis using non-destructive
techniques, like XRD, TEM and SEM, have shown that
the mixture of Copper, Mercury and Sulphur converts
into complex mineral form, comprising of
CuSO4.5H2O, K2(CuSO4)2.6H2O, CuS, KFe2(PO4)2,
SiO2 and CaSO4.2H2O (Figure 1). There were no traces
of any free metals (Indian patent filed).
This complex has shown pancreatitis protective
properties in L-Arginine-induced chronic pancreatitis in
rats10. Large numbers of patients in different parts of
India suffering from different variants of pancreatitis
have volunteered to avail the benefits of this treatment.
Their data is procured following good clinical practice
guidelines, within the ambit of observational research.
Ay. Darpan J., Volume 11, Issue 1, Page 19-22 (2020)
[20]
Figure 1. Chemical composition of AMC
EFFECT ON CA19-9
Pancreatitis is an inflammatory disorder of the pancreas
and could be broadly classified into acute and chronic
pancreatitis11. Acute phases of the disease could be
managed by emergency hospitalizations, intravenous
fluids, painkillers and enzymes but Pancreatitis
continues to progress in spite of all treatments. Up to
40% cases of Pancreatitis progress to cancer of
pancreas12. CA19-9 (Carbohydrate Antigen 19-9) is a
tumor marker which has been identified to evaluate the
progression/ regression of Chronic Pancreatitis and
cancer of pancreas13. It has been reported that the high
values of CA19-9 could be reversed by using
chemotherapeutic agents or post-surgical measures.
Hence, the disease course of chronic pancreatitis and
pancreatic cancer could be measured by the values of
CA19-913.
METHODOLOGY
An observational data was collected in forty nine
patients suffering from Pancreatitis who had elevated
CA19-9 levels (Level more than 37 U/mL). Nine of
these patients were female and forty were male with
disease history ranging from one month to fourteen
years. Their ages varied from six to sixty seven years
(Figure 2).
The patients were prescribed AMC at a dose of 3-4
mg/kg body weight along with 1600-2400 calorie
balanced daily diet, a regulated lifestyle and moderate
rest. Ayurvedic treatment for Pancreatitis is a one year
long protocol. These patients were asked to get their
serum CA19-9 levels evaluated periodically.
<40 years >40 years
37
12
Figure 2. Age groups of the patients (n=49)
Marked lowering effect on CA19-9 was observed
in these cases after administration of AMC (Figure 3).
In majority of the cases, the first effect started within
first ten to forty days. The said effect was sustainable
and there was no adverse effect. Presently, patients of
Pancreatitis have been treated and the effect is depicted
below.
185.97 212.96
154.53
576.13
61.06
193.98
85.14
190.33
93.09 89 61.59
519.44
45.08
91.69
46.17 32.85
0 10 0 20 0 40 0 60 0 120 0 200 0 360 0 600
Pre Post
n=17
n=13
n=5
n=3
n=4
n=2
Days
Figure 3. Lowering effect on CA19-9 levels; compared using mean levels for all days at initial & final points (n=49)
Ay. Darpan J., Volume 11, Issue 1, Page 19-22 (2020)
[21]
RESULT
These observations establish strong prima facie effect
of Copper based mineral complex in lowering CA19-9
in patients of Pancreatitis.
DISCUSSION
Cancer is an uncontrolled growth and could be
considered as a progressive and irreversible
inflammatory disorder14. This fact is more evident in
pancreatic cancer where up to 40 % cases of Chronic
Pancreatitis progress to pancreatic cancer12. This
progression is more visible among patients who are
more than 40 years of age; up to 78% cases convert to
pancreatic cancer in this age group.
In recent years, there is an up-rise in the number of
patients of pancreatic cancer which still remains
incurable15. Nearly 9% patients have more than five
years survival. In the above pretext, the CA19-9
lowering effect of AMC in patients of Pancreatitis
might open an avenue to develop a preventive model
for pancreatic cancer. It is imperative to mention that
CA19-9 levels more than 300 U/mL is presently
considered confirmatory of pancreatic cancer16. In this
clinical study, it has been observed that CA19-9 values
have a declining trend after administration of AMC,
which in itself is an unforeseen effect of any natural
compound.
The result of the study is also helpful in the
revalidation of ancient knowledge of strong anti-
inflammatory properties of tamra. The clinical and
experimental studies following modern parameters
could be considered as revalidation of that wisdom
only.
Though the preliminary chemistry and safety along
with experimental and clinical efficacy are available
and its benefits are being extended to many sufferers,
there is a need to develop this approach further to
understand its intrigue chemistry, mode of action,
duration and limitations.
CONCLUSION
Copper based mineral complex could be developed as a
potential anti-inflammatory, preventive and curative
agent for pancreatitis and early stage of pancreatic
cancer.
CONFLICT OF INTEREST
Authors declare no conflict of interest.
ACKNOWLEDGEMENT
We acknowledge the well-wishers of VCPC Research
Foundation for supporting these studies. We also
appreciate the support of the patients and their families
for consenting to share the medical records.
REFERENCES
1. Prakash VC, as dictated by his Guru Maharaj,
'Dhatu vigyan': Unpublished handwritten booklet;
1945
2. Sharma V, Chaudhary AK. Concepts of Dhatu
Siddhanta (theory of tissues formation and
differentiation) and Rasayana; probable
predecessor of stem cell therapy. Ayu.
2014;35(3):231236.
3. James F. Collins, Leslie M. Klevay,
Copper, Advances in Nutrition, Volume 2, Issue 6,
November 2011, Pages 520522.
4. Whitehouse, M.W., Walker, W.R. Copper and
inflammation. Agents and Actions 8, 8590 (1978)
5. Gordon, Starkebaum; John, M. Harlan (April
1986). "Endothelial cell injury due to copper-
catalyzed hydrogen peroxide generation from
homocysteine". J. Clin. Invest. 77 (4): 13706.
6. Li, Yunbo; Trush, Michael; Yager, James (1994).
"DNA damage caused by reactive oxygen species
originating from a copper-dependent oxidation of
the 2-hydroxy catechol of
estradiol". Carcinogenesis. 15 (7): 14211427.
7. NCI CAM News, OCCAM, US NIH, Fall 2010,
Volume 5, Issue 2
8. Prakash VB, Prakasham S, Sharma S et al. Impact
evaluation of Ayurvedic Treatment Protocol on
three hundred nineteen cases of different variants
of Pancreatitis. Pancreat Disord Ther 2018, 8:2
9. Prakash VB, Prakasham S, Sharma S et al.
Pancreas, Volume 48, Number 10,
November/December 2019, Pg: 1509.
10. Prakash VB et al. Anti-Inflammatory Properties of
a Processed Copper Complex in L-
Arginine Induced Pancreatitis - Two Experimental
Studies, EC Gastroenterology and Digestive
System, 6.7 (2019): 519-524.
11. Banks PA, Conwell DL, Toskes PP. The
management of acute and chronic
pancreatitis. Gastroenterol Hepatol (N Y). 2010;6(2
Suppl 3):116.
12. Howes N, Neotolemos JP. Risk of pancreatic
ductal adenocarcinoma in chronic pancreatitis. Gut.
2002;51:765-766.
Ay. Darpan J., Volume 11, Issue 1, Page 19-22 (2020)
[22]
13. Koom WS, Seong J, Kim YB et al. CA 19-9 as a
Predictor for Response and Survival in Advanced
Pancreatic Cancer Patients Treated With
Chemoradiotherapy. Int J of Rad Oncol. 2009;
73(4):1148-1154.
14. Cooper GM. The Development and Causes of
Cancer. The Cell: A Molecular Approach. 2nd
edition. Sunderland (MA): Sinauer Associates;
2000.
15. Rosenweig A. Increase in Pancreatic Cancer
diagnosis expected in 2019. Pancreatic Cancer
Action Network. Available at:
https://www.pancan.org/news/increase-in-
pancreatic-cancer-diagnoses-expected-in-2019/.
16. Nouts A , Lévy P , Voitot H , et al. Diagnostic
value of serum Ca 19-9 antigen in chronic
pancreatitis and pancreatic adenocarcinoma.
Gastroenterologie Clinique et Biologique [01 Feb
1998, 22(2):152-159].
Article received on January 04, 2020; Accepted on January 15, 2020
© Author(s) and Ayush Darpan Journal. All rights reserved.
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
Background: Recurrent Acute/Chronic Pancreatitis (RA/CP) is an inflammatory disorder of the pancreas. The disease is progressive in nature and may turn fatal in due course. The aetiology of this inflammatory condition majorly remains mysterious, especially in Indian context, where majority of the patients of RA/CP are non-alcoholics and non-tobacco users with no family history of the disease. An Ayurvedic Mineral Complex (AMC) has shown significant improvement in the clinical conditions of pancreatitis patients and significantly reduced acute exacerbations and emergency hospitalizations in a number of cases. The present set of studies was carried to understand the mechanism of AMC. Methodology: AMC was evaluated for its pancreatitis protective properties at different doses in an existing model of L-Arginine induced pancreatitis in albino male wistar rats and compared to Methylprednisolone, a known anti-inflammatory agent. The study was carried in two phases, with three different doses of AMC used in each phase. Results: The studies indicate that AMC was well tolerated. It did not cause mortality or any clinical signs of toxicity in male wistar rats, who were given a daily dose of AMC for twenty-one days. There was no change in body weight and food consumption pattern. It also decreased the oxidative stress, inflammatory cytokines and severity of inflammatory condition in pancreas by reducing structural changes. The best pancreatitis protective effect of AMC was observed at doses of 25 mg/kg and 19 mg/kg body weight. Conclusion: The results of the aforesaid studies validate the stated clinical efficacy of AMC by showing its strong pancreatitis protective properties. AMC might be developed as a potential anti-inflammatory agent.
Article
Full-text available
Pancreatitis is an inflammatory disorder of the pancreas, affecting its endocrine and exocrine function. It is mainly associated with abdominal pain, vomiting, nausea, indigestion, steatorrhea, weight loss and diabetes. There are many variants of pancreatitis that have been broadly divided into acute and chronic pancreatitis. In both the conditions, patients may suffer with recurring episodes of the aforesaid symptoms with progression of the disease. Pancreatitis is conservatively managed by emergency hospitalizations, lifelong pancreatic enzymes and supplements with modifications in diet and lifestyle. Advance surgical intervention is also being used in some cases to provide long term solution. However, the benefits of such procedures are limited to certain pockets of the world. Owing to unpredictable nature of the disease and limitations of treatment possibilities, pancreatitis adversely affects psychological, physical and financial status of the patients. In this scenario, many patients opt for alternate medicines. A North India based Ayurvedic clinic has earned reputation in bringing complete and sustainable relief in significant number of cases of Recurrent Acute/ Chronic Pancreatitis (RA/CP). A data on 319 well diagnosed cases demonstrates that Ayurvedic Treatment Protocol (ATP) has been able to bring complete relief in significant number of patients, without causing any side effect. Statistical analysis of the data shows that the treatment brought significant improvement in weight and reduction in frequency of attacks. ATP comprises of a few Ayurvedic formulations that are prescribed for a period of one year, along with regulated diet and lifestyle as well as complete physical and mental rest. The main Ayurvedic formulation used in the treatment is Amar. Experimental studies conducted using Amar have demonstrated its protective properties against pancreatitis. Further research is being conducted for the systematic and scientific development of this specialized ATP.
Article
Full-text available
Quick Response Code: attracted the attention of biologists and medical scientists for a long time. These provide materials for regenerative medicine. [4] In 1998, researches in the US found a way of harvesting stem cells, a type of primitive cells, from embryos and maintaining their growth in the laboratory, and thus started the era of stem cell researches. [5] Theory of stem cell has arrived in the current trend of life sciences. This seems to be more similar to Dhatu Siddhanta (theory of tissues formation and differentiation) of ancient wisdom. Normal functioning of the cell is always influenced by various factors such as stress, chemical agents, diseases and environmental hazards. Yet, the cell survives and continues the function by means of adaptation. [6] As age progresses, various changes occur at every cell level. To prevent the aging through Rasayana (rejuvenation) therapy is a unique approach of Ayurveda. Doctrine of Dhatu Siddhanta (Theory of tissues formation and differentiation) The basic theory of Ayurveda is based on the state of equilibrium of Tridosha, Saptadhatu and Trimala. [7] All these are nourished well initially by the influence of potency of individual Jatharagni (digestive energy) after consuming the food. Then, the productive nutrients (Ahara Rasa) are passed into each level of Dhatu (bodily tissues) for nourishment.
Article
Full-text available
Article
Full-text available
Pancreatitis, which is most generally described as any inflammation of the pancreas, is a serious condition that manifests in either acute or chronic forms. Chronic pancreatitis results from irreversible scarring of the pancreas, resulting from prolonged inflammation. Six major etiologies for chronic pancreatitis have been identified: toxic/ metabolic, idiopathic, genetic, autoimmune, recurrent and severe acute pancreatitis, and obstruction. The most common symptom associated with chronic pancreatitis is pain localized to the upper-to-middle abdomen, along with food malabsorption, and eventual development of diabetes. Treatment strategies for acute pancreatitis include fasting and short-term intravenous feeding, fluid therapy, and pain management with narcotics for severe pain or nonsteroidal anti-inflammatories for milder cases. Patients with chronic disease and symptoms require further care to address digestive issues and the possible development of diabetes. Dietary restrictions are recommended, along with enzyme replacement and vitamin supplementation. More definitive outcomes may be achieved with surgical or endoscopic methods, depending on the role of the pancreatic ducts in the manifestation of disease.
Article
Full-text available
To investigate the significance of carbohydrate antigen 19-9 (CA 19-9) levels for predicting response and survival in pancreatic cancer (PC) treated with concurrent chemoradiotherapy. We retrospectively reviewed data from 69 patients with PC between 1999 and 2005. All patients had elevated CA 19-9 levels before treatment. CA 19-9 levels (pre- and posttreatment CA 19-9) and their decline were analyzed for radiologic response and overall survival. Seventeen patients (25%) had a 50% or greater reduction in tumor size within 3 months of chemoradiotherapy (1 complete response, 16 partial responses). CA 19-9 decline was significantly correlated with radiologic response (p = 0.03). The median survival time (MST) was 12 months (range, 4-48 months), and 1-year survival rate was 44%. Pretreatment CA 19-9 > 1,200 U/mL (MST, 13 vs. 8 months; p = 0.002), posttreatment CA 19-9 >100 U/mL (MST, 17 vs. 10 months; p = 0.0003), and CA 19-9 decline <or=40% (MST, 13 vs. 10 months; p = 0.005) were the strongest and most unfavorable prognostic factors. In addition, patients with multiple unfavorable CA 19-9 levels had significantly worse outcomes than those without. CA 19-9 decline shows a correlation with radiologic response. The combination of pretreatment CA 19-9 >1,200 U/mL, posttreatment CA 19-9 >100 U/mL, and CA 19-9 decline <or=40% may possibly serve as a surrogate marker for poor survival in advanced PC receiving chemoradiotherapy.
Article
Bonta, Sorenson and others have shown that Cu(II) derivatives are effective anti-inflammatory agents. Some chemical and pharmacological properties of Cu(I) and metallic Cu are discussed. Thio complexes of Cu(I) were prepared and shown to be useful anti-inflammatory agents in rats. Hypotheses are stated concerning the possible therapeutic value of copper in its various oxidation states.
Article
It has previously been proposed that redox cycling between catechol estrogens and their quinones, mediated by cytochrome P450, could lead to the generation of free radicals that would subsequently cause oxidative damage to DNA and proteins that might have a role in hormonal carcinogenesis. Alternative, non-enzymatic mechanisms involving copper have been shown to participate in the oxidation of various chemicals through processes that also result in the appearance of reactive oxygen species and subsequent site-specific oxidative DNA damage. The goal of the present study was to determine whether the 2-hydroxy-catechol of estradiol (2-OH-E2) can be oxidized by copper through a process which generates reactive oxygen species that cause oxidative DNA damage as detected by the appearance of strand breaks in phi X-174 plasmid DNA. Our results show that both single- and double-strand breaks are formed in the presence of Cu(II) plus micromolar concentrations of 2-OH-E2, and 4-OH-E2, in a concentration/time-dependent process. No strand breaks were detected in the presence of Cu(II) or 2-OH-E2 alone. The reaction of 2-OH-E2 with Cu(II) was accompanied by the reduction of Cu(II) to Cu(I), the utilization of O2, and the generation of H2O2. The utilization of O2 and the formation of strand breaks was completely blocked by the Cu(I)-specific chelator bathocuproinedisulfonic acid (BCS) at a ratio of BCS to Cu(II) of 4:1. The appearance of strand breaks was also blocked by catalase and inhibited by the singlet oxygen scavengers sodium azide and 2,2,6,6-tetramethyl-4-piperidone. In contrast the free hydroxyl radical scavengers mannitol and N-tert-butyl-alpha-phenylnitrone were not effective inhibitors; superoxide dismutase had no inhibitory effect. These results are similar to what has been observed by others for the formation of oxidative DNA damage by the H2O2/Cu(II) system and by us for the induction of strand breaks by hydroquinone/Cu(II). Since copper is known to be present in the nucleus, particularly in association with guanines in DNA, our results with 2-OH-E2/Cu(II) together with those of others with H2O2/Cu(II), discussed below, suggest an alternate site-specific mechanism for the formation of oxidative DNA damage associated with estrogen treatment. Furthermore, the results suggest that the oxidative damage results from the localized generation of singlet oxygen or a similar bound reactive entity rather than free hydroxyl radical.
Article
The value of serum Ca 19-9 dosage for pancreatic carcinoma diagnosis has been studied in heterogeneous series. The effect of the complications of chronic pancreatitis and pancreatic carcinoma on serum Ca 19-9 value has not been assessed precisely. The aims of this study were to assess: a) the value of Ca 19-9 to differentiate benign from malignant pancreatic disease; b) the influence of complications (particularly, cholestasis). The studied population included 179 patients: 126 with chronic pancreatitis (25 females, 101 males, 45 with cholestasis) and 53 with pancreatic carcinoma (27 females, 26 males, 37 with cholestasis). At 37 UI/mL threshold, the specificity and sensitivity of Ca 19-9 were 53 and 95%, respectively. Cholestasis was associated with a significant increase of Ca 19-9 in patients with chronic pancreatitis but not in those with pancreatic carcinoma. At 300 UI/mL threshold, the specificity and sensitivity of Ca 19-9 were 95 and 81% in patients without cholestasis and 87 and 81% in those with cholestasis, respectively. Diabetes mellitus was associated with a significant increase of Ca 19-9 only in patients with chronic pancreatitis without cholestasis. Pancreatic calcifications, pseudocysts, cirrhosis, pleural effusion or ascites were not associated with significant variation of Ca 19-9. In patients with pancreatic disease, 300 UI/mL threshold is the most accurate to differentiate benign from malignant disease, whatever the presence of cholestasis.